Dr. Tachi Yamada announced Monday he would be leaving as head of the Gates Foundation’s global health program in June. I wrote about it yesterday, mostly comparing Tachi’s tenure to his two predecessors.
Here are other perspectives.
Seattle Times’ Sandi Doughton emphasized the growth of the program and Tachi’s emphasis on measuring impact: Gates Foundation director of global health retiring
Xconomy’s Luke Timmerman focused on the relationship between Gates and the drug industry, noting that the biotech bunch as disappointed them: Tachi Yamada Stepping Down
Puget Sound Business Journal’s Clay Holtzman quoted Tachi on what he believes he accomplished in his five years and on his cryptic plans for the future: Japan is Gates director’s next step